| Name | Title | Contact Details |
|---|
Bioforum is a data focused CRO, offering a wide range of consulting services, medical writing, data management and bio-statistical support. We are a multi disciplinary team of experts that helps clients comprehend the value of their clinical data simply by making it readily available for monitoring, analysis and ready for submission. Adhering To The Highest Quality We simply don`t compromise on quality. Through our quality management system we ensure both processes and deliverables meet the industry standards and customer requirements. We implement high-quality practices in any project and task we perform and seek continuous improvement.
Peerbridge Health, Inc. is a mobile health IT company seeking to bring independence and precision with remote monitoring capabilities for medical, wellness and performance-based needs including the monitoring of vital signs, with thoughtful design and a seamless user experience.
Nodality is an innovative personalized medicine company focused on improving the efficiency of drug development for therapeutics as well as generating highly predictive companion diagnostics to improve patient care.
Addiction Counseling Services is a North Miami Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.